Search

PMV and Novalis in Rheavita Series A Round

Cresco acted as lead counsel to PMV and Novalis on their €2.5 million Series A investment in Rheavita.

RheaVita has developed the world’s first end-to-end continuous freeze-drying solution to address biopharmaceutical product development, manufacturing and supply needs in order to efficiently reach patients. RheaVita was founded in 2018 as a spin-out of Ghent University.

David Dessers led the Cresco team that advised the investors in this transaction.

More information on this transaction can be found in De Tijd.

For any further information or questions, please contact David Dessers.

Team

David Dessers
Partner

Expertises

innovation
IP
venture capital

Want to stay in the know? Subscribe to our newsletter.

Lange Kievitstraat 118-120
2018 Antwerp            

Kempische Steenweg 293/16 
3500 Hasselt 

T: +32 3 206 75 10
F: +32 3 206 75 11
info@crescolaw.com
LinkedIn

© 2024 CRESCO – All rights reserved – Terms of Use – General terms & conditions – Privacy Policy – Cookie Policy – Design & development by Concepstudio

Close
Close